Antipsychotic medications, psychological side effects and treatment engagement.
نویسنده
چکیده
Patient complaints of antipsychotic-induced apathy, emotional indifference, mental “fogginess,” “blankness,” and “clouding,” among others, are undoubtedly familiar to practicing psychiatric clinicians. This “family” of subjective psychological side effects, variously dubbed “neuroleptic dysphoria” (Awad & Voruganti, 2005; Singh & Smith, 1976), “behavioral toxicity” (Hollister, 1957; Van Putten & Marder, 1987), and “neurolepticinduced psychic indifference” (Healy, 1989; Kalinowsky, 1958) has been noted by clinicians and studied by researchers since the introduction of chlorpromazine in the 1950s. Although dopamine has been suspected to play a role in this negative subjective “syndrome” for over half a century, direct links between dopamine antagonism—antipsychotics, primary mechanism of action—and dysphoria have been clarified only recently. As Awad and Voruganti (2005) detail, research regarding subjective dysphoria has mostly taken one of two approaches: (1) comparing correlations between side effects and rates of dopamine receptor occupancy, utilizing antipsychotics with differing receptor occupancy profiles (e.g., Kirsch, Ronshausen, Mier & Gallhofer, 2007; Mizrahi et al., 2007), and (2) using selective dopamine depleting drugs such as alphamethyl-para-tyrosine (AMPT) to induce phenomenologically identical “neuroleptic dysphoria.” With respect to the second approach, Voruganti and colleagues (Voruganti & Awad, 2006; Voruganti et al., 2001) have used AMPT in medication-free schizophrenia patients to successfully trigger a cascade of negative affects beginning with anhedonia, “clouded thinking,” and amotivation and ultimately leading to social withdrawal and a state of explicit subjective distress. de Haan, Booij, Lavalye, van Amelsvoort, and Linszen (2005) have also produced AMPT-induced dysphoria in a health subject, documenting a similarly complex array and cognitive and behavioral effects. The complexity of these effects—impacting emotion, cognition, motivation, and behavior—cannot be overemphasized, an unsurprising fact given the complexity and controversy
منابع مشابه
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia
Introduction: Hyperprolactinemia is a common serious side effect of antipsychotic medications that are currently used in the treatment of patients with schizophrenia. Pharmacogenetic approaches offer the possibility of identifying patient-specific biomarkers for predicting the risk of this side effect. We investigated a possible relationship between variants (SNPs) in genes for cytochrome 2D6 (...
متن کاملTardive dyskinesia: natural history studies assist the pursuit of preventive therapies.
Contemporary thinking about tardive dyskinesia is undergoing a quiet revolution. In the fourth decade following the introduction of neuroleptic medications for the treatment of schizophrenia, tardive dyskinesia research has moved from debates over its very existence to careful, scholarly sub-typing of clinical variants. Investigators are also beginning to elucidate the epidemiology and natural ...
متن کاملP-188: Mammary Gland Changes during Chlorpromazine Treatment in Female Rats
Background: Antipsychotic drugs are medications used to treat schizophrenia and other psychotic disorders. Antipsychotic drugs can cause unwanted side effects. Hyperprolactinemia is an important but neglected adverse effect. The aim of the this study was to consider the effects of Chlropromazine -induced hyperprolactinaemia on mammary glands of female rats . Materials and Methods: In this study...
متن کاملEvidence base for using atypical antipsychotics for psychosis in adolescents.
Atypical antipsychotic medications have been the first line of treatment for adolescents with psychosis in the past couple of decades. Till the late 90s, there were very few randomized controlled trials (RCTs) on the treatment of adolescents with psychosis, although a fifth of schizophrenia starts during adolescence. Most of the treatment guidelines for adolescents with psychosis were derived f...
متن کاملUse of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.
Use of concomitant medications with antipsychotic agents in the treatment of schizophrenia is common but lacks a clear scientific rationale. We evaluated concomitant medication usage during the first 6 months of the prospective, observational, European Schizophrenia Outpatient Health Outcomes (SOHO) study, examining its frequency, variation according to type of antipsychotic drug used, and impa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Issues in mental health nursing
دوره 33 7 شماره
صفحات -
تاریخ انتشار 2012